|
|||||
|
|
Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα |
|
| Authors: | Hao Yang Kai Zhao Qian Wang Li Zhao Xiaotang Wang Zhiyu Li Na Lu Qinglong Guo |
| Affiliation: | 1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, People's Republic of China;2. Department of Chemistry and Biochemistry, Florida International University, Miami, FL |
| Abstract: | |
| Keywords: | oroxylin A differentiation AML PPARγ RXRα |